Our group including the very smart @MattSpinelliMD was asked to comment on the DANMASK study found here: acpjournals.org/doi/10.7326/M2…. Others have already smartly commented that implementation science is the way to study mask wearing but here goes:
First the study team (many cardiologists in Denmark) should be commended for performing a randomized controlled trial of a non-pharmaceutical intervention (mask-wearing) in the early days of a pandemic; there are study design flaws that will impair our ability to draw conclusions
The study was a non-blinded study of providing 50 surgical face masks tor community participants spending >3; hours outside of the home in April-May (intervention group) versus the standard of care of Denmark not recommending widespread use of face masks in the community at time
Flaw#1: Underpowering: This study conducted during a time of declining incidence in Denmark (…id19-country-overviews.ecdc.europa.eu) so study underpowered (classic Type II error) to look at the outcome. Indeed -few outcomes in this trial, which demonstrates this limit in statistical power,
regardless of the sample size calculations. Flaw #2: Randomization at individual rather than community level: Other studies have shown that the most common source of infection with SARS-CoV-2 is from household contacts. By designing the study as an individual-level rather than a
Flaw 3: Flawed outcome metrics: Use of a home point-of-care antibody test with limited sensitivity (sensitivity is likely even less than 83% given that samples used in validation studies typically come from symptomatic participants with positive PCR tests) decreased study power.
and limited number of outcomes further. Hypothesis that mask-wearing could increase the proportion of asymptomatic infections if infection occurs mentioned, but study is not designed to show this difference - we have talked about T cells (not antibodies) to detect past infection!
Participants had to prick own finger for antibody home testing, and then mail their results back in (subject to underreporting, forgetting) and (fewer times) collect their own OP/NP swabs
Flaw #4: Self-reporting of results introduces bias: Use of self-reported results on this test introduces further measurement error and potential bias, in an unknown direction, which is impossible to sort out without confirmatory testing
Flaw #5: Given low community-level adherence to masking during this time period, masks were at a disadvantage, given that they are more effective at preventing infection from an infectious source.
Flaw #6: Community norms and global recommendations could influence mask wearing in each group, leading to misreporting: Participants in the intervention early on said they experienced social harms from wearing the masks, possibly lead to low adherence and over-reporting
Later in the study, the control group was likely to be influenced by increasing promotion of masking as a non-pharmaceutical intervention worldwide, and likely under-reported their mask wearing. 20% of participants did not complete the study.
And finally, to be fair, the small reduction in incidence seen in this study was acknowledged, as were most of the limitations so the authors should be commended on this important RCT! But don't think it changes the recommendation/importance of masking.
Here is an editorial published simultaneously with the paper covering many of the same points and stressing this RCT does not mean that community-based mask wearing is not an important pillar of control:
acpjournals.org/doi/10.7326/M2…
And one more important editorial published simultaneously by Dr. Thomas Frieden that ends with "Masks have been shown to protect others and, despite the reported results of this study, probably protect the wearer. Maximum benefit of masking is likely to result from combination
of source control and wearer protection. If everyone wears a mask when near others, everyone is safer.
acpjournals.org/doi/10.7326/M2…
I am really bad at twitter right? that was so long!
Consulted with the amazing @dvgbiostat and a few more flaws to the study.
Flaw#7: Assessment of risk: There is no assessment of the nature of SARS-CoV exposure in the two groups. They are spending >3 hours out of the house? Doing what? Occupational? country partial lockdown
Flaw #8: Definitions of adherence: Adherence to mask wearing in the intervention group is quite low (47%) and we know from many other fields and studies that self-reported adherence usually overestimates actual adherence. Also, no assessment of adherence in relation to exposure.
Flaw #9: Since they mentioned our viral inoculum hypothesis: In terms of exploring whether mask wearers could have milder infections, there are no details on the clinical course of the detected infections- so not investigated
In sum, testing this ? via an RCT (rather an observational or implementation design) is odd because of contamination issues; it is easy for those randomized to not wear masks to “drop in” and adherence in those randomized to wearing masks is both hard - and critical - to assess

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Monica Gandhi

Monica Gandhi Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @MonicaGandhi9

17 Nov
Got a call from science reporter about what we hope & expect from Biden administration on COVID19 response, should be organized and consistent on NPIs and testing. But HIV expertise from advisors is essential to inform public health messaging, I think.
Why? Because HIV doctors have learned over many years and in close contact with their patients to NOT use stigmatizing messaging ("you got COVID? what were you doing??!) and to use kind, harm-reduction-based ways to message on prevention and adherence
I have so many patients right now (I treat patients with HIV) who are totally traumatized by the punitive and harsh aspect of public health messaging right now and make suggestions on how to make messaging more effective via gentleness, kindness, acknowledging loneliness and pain
Read 4 tweets
16 Nov
The interim results of the Moderna vaccine trial released this morning are thrilling. Like the Pfizer/BioNTech vaccine, the Moderna vaccine (called mRNA-1273) is an mRNA vaccine and this trial enrolled 30,000 participants, 42% of whom were high-risk (7000 over 65 years and 5000
<65 years old with comorbid conditions) and 11,000 of whom were from communities of color. The press release of the interim results of the phase 3 trial of the Moderna vaccine shows a 94.5% efficacy rate at 95 infections (e.g. 5 infections in the vaccine group; 90 in the placebo
group). Vaccine trials often have a secondary endpoint of mitigating severe disease and all 11 of the severe cases of COVID-19 occurred in the placebo group. The vaccine trial will go up to 151 infections and 2 months for safety data before Moderna will file for an emergency use
Read 6 tweets
12 Nov
HI all, we submitted a paper on this today but we want to go from cheapest interventions to most expensive in our response. Cheapest are NPIs (masks, hand hygiene, distancing, ventilation), then more expensive (testing, I&Q, contact tracing), then most expensive (treatments).
Cheapest are "easiest" to enact and yet take behavior change (e.g. masking) so is that so easy? Not really, it is why we came up with prevention strategies for HIV ("biomedical prevention strategies" like PrEP) that didn't rely solely on behavior (condoms)- then it turns out
PrEP ALSO relies on behavior (mainly daily pill taking- this is what I study, adherence in HIV). So, I am not saying behavior change (masks) is easy, I am saying that we as a populace have to trust tbose who recommend them and I so I think we have to turn to building trust
Read 9 tweets
12 Nov
The word "lockdown" is really disturbing. San Francisco has essentially been locked down x 8 months. Testing is helpful but acknowledge limitations of each test. Non-pharmaceutical interventions (distance, masks, hand hygiene, ventilation) work.
and everyone has to decide for themselves their level of fear (I call it "strata of fear", stratosphere) which will determine what they do in terms of being with each other (e.g. is it more ethical to stay away from demented elderly relative or more ethical to see them with NPI?)
No one has seen a movie or performance in 8 months; very few things open (at least in SF) so lockdown hard. What you do to behave "ethically" towards family/friends should be a personal decision, right? The elderly, widows, orphans may be more scared of no contact than contact.
Read 7 tweets
4 Nov
I & my co-authors suggested a hypothesis, acknowledged limitations, and we & others are trying to study it further (inoculum & severity of disease). Science has never been a fixed thing – people got KILLED for thinking of scientific ideas that didn’t fit the predominant paradigm.
A hypothesis is based on an idea; a theory gathers more (but indirect) evidence for the hypothesis; a fact has been proven by usually experimental means (and even that can be disputed based on bias)
There are two things that masks may do- decrease transmission and decrease severity of disease by decreasing viral load. Even decreasing transmission has been questioned because physical sciences can show that a virus can leak around a mask.
Read 15 tweets
3 Nov
How do we show viral inoculum related to severity of disease? We can't do this with dangerous viruses like SARS-CoV-2 (only animal models like this one): pnas.org/content/117/28…
Don't think this relationship is true of all viruses, but seems to be true of some viruses where human experimentation was possible because they are not as dangerous (e.g. giving human volunteers doses of virus and showing that a higher dose gives more symptoms).
Here are few paper showing this for influenza with 'human inoculation" experiments: pubmed.ncbi.nlm.nih.gov/30770534
Read 8 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!